OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Greif Inc/  US3976241071  /

IEX
2024-04-23  8:25:35 PM Chg. +0.48 Volume Bid8:26:53 PM Ask8:26:53 PM Market Capitalization Dividend Y. P/E Ratio
62.27USD +0.77% 3,809
Turnover: 236,139.95		 62.21Bid Size: 200 62.33Ask Size: 105 1.6 bill.USD 3.25% 10.00
GlobeNewswire 04-16 Greif Prepares For Opening of New Manufacturing Facility in Dallas, Texas
GlobeNewswire 04-03 Greif Named 2024 Gallup Exceptional Workplace Award Winner
GlobeNewswire 04-01 Gabelli Funds to Host 10th Annual Waste & Environmental Services Symposium Thursday, April 4, 2024
GlobeNewswire 03-26 Greif Completes Acquisition of Ipackchem
GlobeNewswire 03-20 InStride Celebrates Five Years of Growth, Innovation and Social Impact
GlobeNewswire 03-18 UPDATE - Gabelli Funds to Host 10th Annual Waste & Sustainability Symposium Thursday, April 4, 2024
GlobeNewswire 03-18 Gabelli Funds to Host 10th Annual Waste & Sustainability Symposium Thursday, April 4, 2024
GlobeNewswire 02-26 Greif, Inc. Declares Quarterly Dividend
GlobeNewswire 02-05 Greif, Inc. Announces 2024 First Quarter Earnings Release and Conference Call Dates
GlobeNewswire 02-02 Greif Announces New Partnership with the Columbus Blue Jackets NHL Franchise
GlobeNewswire 01-12 Greif and IonKraft Announce New Pilot-Project Partnership to Revolutionize Industrial Packaging  
GlobeNewswire 01-05 Greif Announces Price Increase for Uncoated Recycled Paperboard (URB), Tube and Core and Protective ...
GlobeNewswire 2023-12-06 Greif Reports Fourth Quarter and Fiscal 2023 Results
GlobeNewswire 2023-12-05 Greif, Inc. Declares Quarterly Dividend
GlobeNewswire 2023-11-08 Greif, Inc. Attends Baird Global Industrial Conference; Reaffirms Fiscal Year 2023 Guidance
GlobeNewswire 2023-10-31 CORRECTION - Greif Plans to Acquire IPACKCHEM
GlobeNewswire 2023-10-31 Greif Plans to Acquire IPACKCHEM
GlobeNewswire 2023-10-10 Greif, Inc. Announces 2023 Fourth Quarter Earnings Release and Conference Call Dates
GlobeNewswire 2022-01-14 Nabriva Therapeutics Adjourns Extraordinary General Meeting of Shareholders
GlobeNewswire 2021-12-22 Nabriva Therapeutics to Adjourn Extraordinary General Meeting of Shareholders on December 22, 2021
GlobeNewswire 2021-12-21 Nabriva Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference
GlobeNewswire 2021-11-29 Lefamulin NDA Filed in Mainland China for Treatment of Community Acquired Pneumonia
GlobeNewswire 2021-11-11 Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack
GlobeNewswire 2021-11-09 Nabriva Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire 2021-11-05 Nabriva Therapeutics to Present at the Jefferies London Healthcare Conference